Mbb Public Markets I »

Sarepta Therapeutics shares owned by Mbb Public Markets I

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Mbb Public Markets I from 13F filings

Historical chart of Mbb Public Markets I investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Mbb Public Markets I consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Mbb Public Markets I

Quarter filed Position value Share count Share price at filing
2023-12-31 $386k 4.0k 96.43
2023-09-30 $485k 4.0k 121.22
2023-06-30 $481k 4.2k 114.52

More positions owned by Mbb Public Markets I

Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Teck Resources CL B Call Option (TECK)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Bunge Global Sa Com Shs (BG)
Ishares Msci Brazil Etf (EWZ)
Cameco Corporation Call Option (CCJ)
Freeport-mcmoran CL B Call Option (FCX)
Spdr Ser Tr Portfolio S&p600 (SPSM)
Micron Technology (MU)
CSX Corporation (CSX)
UnitedHealth Call Option (UNH)
Humana Call Option (HUM)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Cabot Oil & Gas Corporation (CTRA)
Vici Pptys (VICI)

View all positions for Mbb Public Markets I

Top funds holding Sarepta Therapeutics

Vanguard Group
BlackRock
Henderson Group
venBio Select Advisor
Wellington Management Company
Farallon Capital Management
Citadel Advisors
Bank of New York Mellon
T. Rowe Price Investment Management
EcoR1 Capital
Jpmorgan Chase & Co
Logos Global Management
Geode Capital Management
Deutsche Bank Aktiengesellschaft
FMR

View all funds holding Sarepta Therapeutics